Search
The transition of Value Research Online has been postponed to take care of some user concerns.
You are welcome to try out the new site at https://beta.valueresearchonline.com

Fredun Pharmaceuticals

Sector: Healthcare | Industry: Drugs & Pharma
R 201.75 2.40  | 1.20% -37.33% 20.46 80.49
BSE Price: Dec 06, 2019 Change R    |  % 1-Year Change P/E Market Cap (R Cr)
BSE Dec 06, 2019 201.75 2.40 1.20% 203.00 199.35 2,196 200.00 - 206.40
Exchange & Time Last Price      Day Change Open Prev Close Volume    1-Day Range
SUBSCRIBE TO THE VALUE RESEARCH STOCK INSIGHT NEWSLETTER
6M Average Volume: 2,739 P/B: 2.01 NSE Code:
52-Week Range: R 183.00 - 500.00 Dividend Yield: 0.32% BSE Code: 539730
TTM EPS: R 9.86 Book Value: R 100.51 Face Value: R 10
Number of stocks currently recommended as 'Buy' by Value Research Stock Advisor: 37
Price Graph
  • Procter & Gamble Health (BSE)
  • S&P BSE Sensex


Please wait while we are fetching data...
Our equity analyst team has sifted through hundreds of companies and selected a short list of stocks that you should invest in.
This list now has 37 stocks on it. Thousands of our members are using stagnant equity markets to buy great stocks at low prices.

Membership is currently available at a 40% to 60% discount. Learn more and become a member
Performance
  YTD 1-Month 3-Month 1-Year 3-Year 5-Year 10-Year
Fredun Pharmaceuticals -40.15 -18.53 -11.38 -37.33 63.32 - -
S&P BSE Small Cap* -8.51 -0.49 7.68 -6.16 3.56 3.23 5.53
S&P BSE Healthcare* -3.24 2.16 4.31 -2.91 -4.93 -2.03 10.33
Company's return has been calculated on basis of BSE's price.
As on Dec 06, 2019
*As on Dec 05, 2019
Key Ratios
Revenue Per Share (R) Earnings Per Share (R) Return on Networth (%)


Please wait
while we are fetching data...


Please wait
while we are fetching data...


Please wait
while we are fetching data...
Annual Ratios (%)
  1-Year 3-Years 5-Years
Growth
Revenue 62.92 31.85 35.44
Net Profit 154.72 60.96 79.07
EPS 168.74 35.83 63.92
Book Value 51.03 84.04 54.88
Average
Operating Margin 11.01 10.04 9.96
Net Margin 4.57 3.31 2.68
Return on Networth 14.59 20.50 20.92
Return on Investment 23.16 19.07 19.22
Interim Growth Ratios (%)
  QoQ YoY YTD
Quarterly
Revenue 12.69 44.33 -1.03
Operating Profit 13.57 -19.35 -54.56
Net Profit 275.97 -61.32 -21.65
EPS 275.94 -61.11 -21.65
TTM
Revenue 8.97 61.83 22.16
Operating Profit -4.16 100.55 11.22
Net Profit -26.09 52.60 -11.81
EPS -25.92 48.18 -9.55
Peer Comparison
  Market Cap
(R Cr)
Revenue
(R Cr)
Net Profit
(R Cr)
Net Margin (%) RoE (%) Price to Book Price to Earnings
Fredun Pharmaceuticals 80.49 118.99 3.93 3.31 14.59 2.01 20.46
Astrazeneca Pharma India 6,631.63 818.54 74.85 8.97 20.03 20.12 88.60
Procter & Gamble Health 7,064.70 894.23 835.89 14.21 73.79 9.06 52.71
Fund Houses invested in the stock
Fund Dec-98 Dec-98 Dec-98 Sep-98 Jun-98
Tata Mutual Fund 1.003 - - - -
Figures given above are % of equity capital
News & Announcements
Contact Information

Company: Fredun Pharmaceuticals Ltd.

Address: 26 , Manoj Industrial Premises, G . D . Ambekar Marg, Wadala, Mumbai, Maharashtra - 400031 | Phone: +91-22-40318111 | Fax: +91-22-40318133

Email: [email protected]

Website: www.fredungroup.com

Registrar & Transfer Agent: Purva Shareregistry (India) Pvt Ltd

Address: Gala No 9, Shiv Shakti, Industrial EstateSitaram Mill Compound, J R Boricha Marg, Gala No 9, Shiv Shakti, Industrial Estate,Sitaram Mill Comp., J R Boricha Marg, Lower Parel [E]

Essential checks
Altman Z-Score
2.94
Piotroski F-Score
6
Modified C-Score
2
3-Years Price to Earnings
20.46
3-Years Price to Book
2.01
Earnings Yield
EBIT / Enterprise value
11.55%
PEG
Price / Earnings to growth ratio
0.59
Related Stocks
  Current Price   Chng %
Astrazeneca Pharma India R2,652.10 -2.42%
Eris Lifesciences R476.35 +7.39%
FDC R206.25 +4.14%
Granules India R121.50 -4.44%
JB Chemicals & Pharma R403.25 +0.41%
Laurus Labs R340.20 -1.05%
Procter & Gamble Health R4,255.45 -1.09%
Strides Pharma Science R378.05 -0.49%
Sun Pharma Adv. Research R153.80 -1.51%
Suven Life Sciences R279.55 +2.46%
As on Dec 06, 15:59